OUTCOMES ASSOCIATED WITH USE OF PHOSPHATE BINDERS IN PERSONS WITH CHRONIC KIDNEY DISEASE STAGES 4 AND 5 IN SPAIN
Por:
Molina, P, Molina, MD, Bover, J, Gimenez-Civera, E, Alonso, CC, Quesada, VE, Pantoja, J, Carrero, JJ and Teruel, JLG
Publicada:
1 may 2022
Resumen:
Filiaciones:
Molina, P:
Hosp Univ Dr Peset, Nephrol, Valencia, Spain
Univ Valencia, Med, Valencia, Spain
FISABIO, Valencia, Spain
Molina, MD:
Univ Alicante, Math, San Vicente Raspeig, Alacanti, Spain
:
Germans Trias Pujol Hosp, Nephrol, Badalona, Spain
Gimenez-Civera, E:
Hosp Clin Univ, Nephrol, Valencia, Spain
Incliva Inst Invest Sanitaria, Valencia, Spain
Alonso, CC:
Hosp Univ Dr Peset, Nephrol, Valencia, Spain
Quesada, VE:
Hosp Univ Dr Peset, Nephrol, Valencia, Spain
Pantoja, J:
Hosp Univ Dr Peset, Nephrol, Valencia, Spain
FISABIO, Valencia, Spain
Carrero, JJ:
Karolinska Inst, Med Epidemiol & Biostat, Solna, Sweden
Teruel, JLG:
Univ Valencia, Med, Valencia, Spain
Hosp Clin Univ, Nephrol, Valencia, Spain
Incliva Inst Invest Sanitaria, Valencia, Spain
|